Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.30
0.07 (5.69%)
At close: Aug 15, 2025, 3:59 PM
1.29
-1.13%
After-hours: Aug 15, 2025, 07:56 PM EDT
Pacific Biosciences of California Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -526.36M | -657.75M | -309.85M | -394.24M | -400.38M | -296.9M | -306.74M | -309.1M | -319.2M | -320.76M | -314.25M | -299.19M | -205.68M | -175.29M | -181.22M | -36.96M | -77.21M | -59.29M |
Depreciation & Amortization | 402.24M | 414.11M | 53.35M | 54.1M | 43.46M | 34.03M | 26.53M | 19.38M | 18.24M | 17.64M | 17.32M | 16.86M | 15.26M | 13.38M | 11.59M | 9.85M | 9.46M | 9.33M |
Stock-Based Compensation | 55.39M | 60.71M | 71.04M | 71.59M | 73.02M | 73.69M | 72.12M | 73.49M | 72.73M | 73.86M | 78.61M | 79.6M | 89.11M | 85.89M | 73.36M | 59.69M | 36.24M | 23.67M |
Other Working Capital | -17.42M | -10.33M | -42.75M | -47.68M | -34.15M | -41.04M | -38.48M | -28.17M | -36.27M | -37.6M | -34.39M | -23.51M | -4.33M | 4.13M | 22.6M | -82.25M | -90.49M | -95.02M |
Other Non-Cash Items | -64.91M | 26.86M | 20.19M | 92.94M | 94.61M | 1.56M | 19.24M | 24.33M | 28.86M | 22.75M | 8.72M | 1.31M | -2.91M | 2.52M | 54.64M | 55.29M | 55.17M | 54.93M |
Deferred Income Tax | -751K | -751K | -205K | -718K | -11.42M | -12.73M | -12.73M | -12.01M | -1.31M | n/a | n/a | 1.18M | -92.32M | -91.11M | -90.54M | -94.59M | -1.09M | -2.31M |
Change in Working Capital | -15.16M | -17.62M | -40.58M | -56.69M | -52.01M | -41.18M | -58.96M | -59.57M | -60.68M | -72.72M | -53.97M | -34.46M | -15.77M | -2.5M | 21M | -87.02M | -93.45M | -105.28M |
Operating Cash Flow | -149.55M | -174.43M | -206.06M | -233.02M | -252.74M | -240.21M | -259.22M | -262.18M | -260.05M | -278.87M | -263.21M | -234.35M | -211.96M | -167.1M | -111.18M | -93.73M | -70.89M | -78.96M |
Capital Expenditures | -2.77M | -8.7M | -6.19M | -6.59M | -8.21M | -9M | -8.84M | -11.9M | -15.26M | -17.01M | -16.93M | -14.69M | -11.62M | -9.17M | -5.93M | -3.16M | -2.57M | -1.32M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -102K | 96.22M | 165.05M | 165.23M | 107.24M | 10.91M | -57.92M | -58.1M | -319.79M | -319.79M | -319.79M | -474.79M | -155M | -155M |
Purchase of Investments | -313.06M | -368.55M | -498.63M | -620.98M | -583.25M | -715.18M | -756.57M | -688.64M | -678.58M | -599.71M | -442.79M | -438.52M | -593.73M | -999.99M | -988.05M | -996.15M | -889.48M | -364.75M |
Sales Maturities Of Investments | 472.65M | 580.62M | 628.83M | 626.77M | 810.01M | 767.31M | 770.12M | 852.22M | 657.01M | 618.2M | 575.8M | 554.64M | 681.02M | 684.3M | 635.24M | 476.32M | 277.28M | 209.25M |
Other Investing Acitivies | -5M | -5M | n/a | n/a | n/a | n/a | -68.83M | -69.01M | -10.91M | -67.18M | 47.35M | 116.12M | -261.77M | -664.75M | -701.87M | -615.46M | -358.77M | 97.93M |
Investing Cash Flow | 151.82M | 203.37M | 124M | -809K | 218.45M | 43.02M | 4.6M | 151.58M | -36.83M | 1.48M | 116.08M | 101.43M | -244.12M | -644.65M | -678.53M | -842.78M | -614.77M | -156.82M |
Debt Repayment | 490K | 338K | n/a | -935K | -1.42M | -1.73M | -1.84M | -1.82M | -1.75M | -1.68M | -1.61M | -1.18M | -770K | -465K | 895.54M | 895.54M | 895.54M | 895.62M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -50.69M | -50.69M | -50.69M | -82.09M | -86.95M | -91.2M | -83.97M | -625K | 7.78M | 12.87M | 11.23M | 11.31M | 307.42M | 309.54M | 251.7M | 282.56M | -17.09M | -20.06M |
Financial Cash Flow | -47.43M | -47.58M | -42.99M | -74.39M | -75.98M | -80.55M | 108.89M | 191.31M | 195.23M | 200.4M | 9.62M | 10.13M | 306.65M | 309.07M | 1.17B | 1.29B | 1.1B | 1.1B |
Net Cash Flow | -44.77M | -17.75M | -124.15M | -307.28M | -109.72M | -274.47M | -145.68M | 80.72M | -101.66M | -74.74M | -137.51M | -122.79M | -149.43M | -503.82M | 379.87M | 357.92M | 416.25M | 859.54M |
Free Cash Flow | -152.31M | -183.13M | -212.25M | -239.61M | -260.95M | -249.22M | -268.07M | -274.08M | -275.31M | -295.88M | -280.14M | -249.04M | -223.57M | -176.27M | -117.11M | -96.89M | -73.46M | -80.29M |